Epic SCIENCES’ CTC-based

liquid-biopsy test for AR-V7

A RARE LEVEL OF CONFIDENCE

Virtually all men with metastatic prostate cancer will eventually develop mCRPC, an advanced stage of the disease. The CTC-based liquid-biopsy test for AR-V7 is the first and only Medicare reimbursed, clinically-validated predictive CTC liquid biopsy test for mCRPC.

NO CELL LEFT BEHIND™

Our unique approach to detection of rare cells is bias-free and can capture, identify, and characterize all the circulating tumor cells (CTCs) in a blood sample including those that others miss.

ABOUT THE TEST

HOW IT WORKS

Epic Sciences’ technology can see, identify and characterize nearly all the circulating tumor cells (CTCs) in a blood sample, and can predict their response or resistance to one class of drugs. Specifically, the Epic Sciences’ AR-V7 test identifies patients who are likely to be resistant to androgen-directed therapies such as abiraterone, enzalutamide, or apalutamide. Once alerted to the likelihood of drug resistance, physicians will be empowered to make alternative treatment choices that can improve outcomes and reduce the costs of ineffective treatment.

BLOOD DRAW

Our liquid-biopsy test requires a sample of each patient’s blood to be sent to Epic Science’s clinical laboratory.

PROCESSING

The sample is processed for characterization of nuclear localized AR-V7+ CTCs in our CAP-accredited clinical laboratory.

RESULTS

Patient results are reported to the ordering physician, reporting the patient as either AR-V7+ (positive) or AR-V7- (negative).

PATIENT CRITERIA

The AR-V7 Nucleus Detect assay is ideal for late-stage metastatic prostate cancer patients who:

  • Have confirmed mCRPC

  • Have received and failed an AR-targeted therapy
  • Are considering additional AR-targeted therapies

  • For more information visit the Exact Sciences Eligibility Page.

In the U.S., available exclusively through Exact Sciences.

Physicians can order the test through Exact Sciences physician portal.

All tests are performed by Epic Sciences at our centralized, CAP accredited and CLIA-certified laboratory in San Diego, California.

AR-V7 CTC Liquid Biopsy Test - A Rare Level of Confidence

QUESTIONS OR REQUESTS? CONTACT US.